Darien Pharmacy Pays $75,000 to Settle Allegations Under the
JAN 14 -- Steven W. Derr, Special Agent in Charge of the Drug Enforcement Administration for New England and Nora R. Dannehy, Acting United States Attorney for the District of Connecticut, today announced that GRIEB’S DARIEN PHARMACY, a retail pharmacy located at 1021 Post Road in Darien, has entered into a civil settlement agreement with the Government in which it will pay $75,000 to resolve allegations that it violated civil provisions of the Controlled Substances Act.
The allegations against GRIEB’S involved claims that GRIEB’S did not have an accurate inventory of its controlled substances and failed to promptly notify the Drug Enforcement Administration when thefts or losses of controlled substances were discovered as required to by law.
The Controlled Substances Act attempts to create “a closed system” of distribution for controlled substances in which every facet of the handling of the substances, from their manufacture to their consumption by the ultimate user, is subject to pervasive government controls. The Controlled Substances Act aims to prevent the diversion and abuse of legitimate controlled substances and ensure that an adequate supply of those substances meets the medical and scientific needs of the United States.
Diversion of legitimately manufactured drugs is a problem that affects the health, safety and welfare of the country, and shoddy record keeping related to the handling and distribution of these controlled substances will not be tolerated,” stated Acting United States Attorney Dannehy.
This investigation was conducted by investigators from the Drug Enforcement Administration’s Office of Diversion Control in Hartford and the State of Connecticut, Department of Consumer Protection, Drug Control Division.